Lineage Cell Therapeutics, Inc. 10-Q

Item 1. Legal Proceedings The information required by this Item is incorporated herein by reference to Notes to Condensed Consolidated Interim Financial Statements—Note 14. “Commitments and Contingencies” under the heading “Litigation,” in Part I, Item 1, of this Report. From time-to-time we may be involved in a variety of claims or litigation proceedings. Such proceedings may initially be viewed as immaterial but could later prove to be material. Litigation proceedings are inherently unpredictable and excessive verdicts do occur. Given the inherent uncertainties in litigation, even when we can reasonably estimate the amount of possible loss or range of loss and reasonably estimable loss contingencies, the actual outcome may change in the future due to new developments or changes in approach. In addition, such claims or litigation proceedings could involve significant expense and diversion of management’s attention and resources from other matters.